- 現金殖利率: 1.96%、總殖利率: 6.63%、5年平均現金配發率: 42.29%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 0.95 | -19.49 | 0.40 | -20.0 | 0.50 | 0.0 | 42.11 | -0.63 | 52.63 | 24.21 | 94.74 | 11.79 |
2022 (9) | 1.18 | 57.33 | 0.50 | 66.67 | 0.50 | 66.67 | 42.37 | 5.93 | 42.37 | 5.93 | 84.75 | 5.93 |
2021 (8) | 0.75 | -18.48 | 0.30 | -25.0 | 0.30 | -40.0 | 40.00 | -8.0 | 40.00 | -26.4 | 80.00 | -18.22 |
2020 (7) | 0.92 | -33.33 | 0.40 | -33.33 | 0.50 | 25.0 | 43.48 | -0.0 | 54.35 | 87.5 | 97.83 | 35.0 |
2019 (6) | 1.38 | -33.65 | 0.60 | -40.0 | 0.40 | -20.0 | 43.48 | -9.57 | 28.99 | 20.58 | 72.46 | 0.48 |
2018 (5) | 2.08 | 49.64 | 1.00 | 100.0 | 0.50 | 0.0 | 48.08 | 33.65 | 24.04 | -33.17 | 72.12 | 0.24 |
2017 (4) | 1.39 | 0 | 0.50 | 100.0 | 0.50 | 66.67 | 35.97 | 0 | 35.97 | 0 | 71.94 | 0 |
2016 (3) | -0.31 | 0 | 0.25 | -50.0 | 0.30 | 0.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | -0.02 | -109.09 | -106.67 | 0.21 | 23.53 | 61.54 | 0.42 | -16.0 | -43.24 |
24Q2 (19) | 0.22 | -15.38 | -46.34 | 0.17 | 30.77 | 13.33 | 0.50 | 92.31 | 6.38 |
24Q1 (18) | 0.26 | 23.81 | 333.33 | 0.13 | -13.33 | 116.67 | 0.26 | -72.63 | 333.33 |
23Q4 (17) | 0.21 | -30.0 | -36.36 | 0.15 | 15.38 | -21.05 | 0.95 | 28.38 | -19.49 |
23Q3 (16) | 0.30 | -26.83 | -11.76 | 0.13 | -13.33 | 116.67 | 0.74 | 57.45 | -12.94 |
23Q2 (15) | 0.41 | 583.33 | 51.85 | 0.15 | 150.0 | 275.0 | 0.47 | 683.33 | -11.32 |
23Q1 (14) | 0.06 | -81.82 | -76.92 | 0.06 | -68.42 | -45.45 | 0.06 | -94.92 | -76.92 |
22Q4 (13) | 0.33 | -2.94 | 10.0 | 0.19 | 216.67 | 11.76 | 1.18 | 38.82 | 57.33 |
22Q3 (12) | 0.34 | 25.93 | 1233.33 | 0.06 | 50.0 | 400.0 | 0.85 | 60.38 | 88.89 |
22Q2 (11) | 0.27 | 3.85 | 145.45 | 0.04 | -63.64 | -55.56 | 0.53 | 103.85 | 6.0 |
22Q1 (10) | 0.26 | -13.33 | -33.33 | 0.11 | -35.29 | -15.38 | 0.26 | -65.33 | -33.33 |
21Q4 (9) | 0.30 | 1100.0 | -14.29 | 0.17 | 950.0 | -19.05 | 0.75 | 66.67 | -18.48 |
21Q3 (8) | -0.03 | -127.27 | -108.82 | -0.02 | -122.22 | -110.53 | 0.45 | -10.0 | -21.05 |
21Q2 (7) | 0.11 | -71.79 | 37.5 | 0.09 | -30.77 | 50.0 | 0.50 | 28.21 | 108.33 |
21Q1 (6) | 0.39 | 11.43 | 129.41 | 0.13 | -38.1 | 116.67 | 0.39 | -57.61 | 129.41 |
20Q4 (5) | 0.35 | 2.94 | 66.67 | 0.21 | 10.53 | 90.91 | 0.92 | 61.4 | -33.81 |
20Q3 (4) | 0.34 | 325.0 | 0.0 | 0.19 | 216.67 | 0.0 | 0.57 | 137.5 | 0.0 |
20Q2 (3) | 0.08 | -52.94 | 0.0 | 0.06 | 0.0 | 0.0 | 0.24 | 41.18 | 0.0 |
20Q1 (2) | 0.17 | -19.05 | 0.0 | 0.06 | -45.45 | 0.0 | 0.17 | -87.77 | 0.0 |
19Q4 (1) | 0.21 | 0.0 | 0.0 | 0.11 | 0.0 | 0.0 | 1.39 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 0.36 | 42.65 | 34.66 | 3.42 | 13.82 | 0.92 | N/A | - | ||
2024/10 | 0.25 | -21.83 | -11.43 | 3.06 | 11.81 | 0.9 | N/A | - | ||
2024/9 | 0.32 | -3.54 | 12.92 | 2.81 | 14.47 | 1.02 | 0.28 | - | ||
2024/8 | 0.33 | -11.14 | 8.76 | 2.5 | 14.67 | 0.99 | 0.29 | - | ||
2024/7 | 0.37 | 29.83 | 54.07 | 2.16 | 15.63 | 1.0 | 0.29 | 再生膠銷貨金額增加,因塞港原因,部份訂單延至本月出貨 | ||
2024/6 | 0.29 | -16.43 | -3.14 | 1.79 | 9.94 | 0.92 | 0.25 | - | ||
2024/5 | 0.34 | 17.91 | 3.66 | 1.51 | 12.84 | 0.96 | 0.24 | - | ||
2024/4 | 0.29 | -10.35 | 4.56 | 1.16 | 15.86 | 0.86 | 0.27 | - | ||
2024/3 | 0.32 | 32.62 | 20.96 | 0.87 | 20.18 | 0.87 | 0.26 | - | ||
2024/2 | 0.24 | -19.94 | -5.63 | 0.55 | 19.73 | 0.79 | 0.29 | - | ||
2024/1 | 0.31 | 25.53 | 52.57 | 0.31 | 52.57 | 0.81 | 0.28 | 因今年工作天數較多,且銷量及售價皆有提升所致。 | ||
2023/12 | 0.24 | -7.79 | -10.89 | 3.25 | 1.07 | 0.79 | 0.3 | - | ||
2023/11 | 0.26 | -6.17 | 3.73 | 3.0 | 2.18 | 0.83 | 0.29 | - | ||
2023/10 | 0.28 | -0.34 | -5.62 | 2.74 | 2.03 | 0.87 | 0.28 | - | ||
2023/9 | 0.28 | -7.09 | 11.49 | 2.46 | 2.99 | 0.83 | 0.3 | - | ||
2023/8 | 0.3 | 25.86 | -5.56 | 2.18 | 1.98 | 0.84 | 0.3 | - | ||
2023/7 | 0.24 | -18.38 | -7.28 | 1.87 | 3.32 | 0.87 | 0.29 | - | ||
2023/6 | 0.3 | -10.56 | -3.16 | 1.63 | 5.1 | 0.9 | 0.24 | - | ||
2023/5 | 0.33 | 18.93 | 21.16 | 1.34 | 7.13 | 0.88 | 0.25 | - | ||
2023/4 | 0.28 | 3.7 | 23.56 | 1.0 | 3.2 | 0.8 | 0.27 | - | ||
2023/3 | 0.27 | 3.46 | -2.68 | 0.73 | -2.91 | 0.73 | 0.34 | - | ||
2023/2 | 0.26 | 29.43 | 25.56 | 0.46 | -3.04 | 0.73 | 0.34 | - | ||
2023/1 | 0.2 | -26.69 | -25.12 | 0.2 | -25.12 | 0.73 | 0.34 | - | ||
2022/12 | 0.27 | 7.34 | 6.92 | 3.21 | 18.8 | 0.83 | 0.27 | - | ||
2022/11 | 0.25 | -14.64 | 2.66 | 2.94 | 20.04 | 0.81 | 0.27 | - | ||
2022/10 | 0.3 | 17.73 | 23.07 | 2.68 | 21.99 | 0.87 | 0.25 | - | ||
2022/9 | 0.25 | -21.3 | 11.59 | 2.39 | 21.86 | 0.83 | 0.28 | - | ||
2022/8 | 0.32 | 23.55 | 213.77 | 2.13 | 23.2 | 0.89 | 0.26 | 今年同期較去年同期營收增加,係因去年同期重要子公司正原公司因疫情嚴峻持續停工,今年已恢復正常所致。 | ||
2022/7 | 0.26 | -14.75 | 132.76 | 1.81 | 11.21 | 0.84 | 0.27 | 今年同期較去年同期營收增加,係因去年同期重要子公司正原公司因疫情嚴峻持續停工,今年已恢復正常所致。 | ||
2022/6 | 0.31 | 11.91 | 112.72 | 1.55 | 2.26 | 0.8 | 0.36 | 今年同期較去年同期營收增加,係因去年同期重要子公司正原公司因疫情嚴峻持續停工,今年已恢復正常所致。 | ||
2022/5 | 0.27 | 21.29 | 5.96 | 1.25 | -9.27 | 0.77 | 0.38 | - | ||
2022/4 | 0.22 | -18.32 | -19.79 | 0.97 | -12.78 | 0.71 | 0.41 | - | ||
2022/3 | 0.28 | 33.5 | -6.3 | 0.75 | -10.43 | 0.75 | 0.36 | - | ||
2022/2 | 0.21 | -22.81 | -17.51 | 0.47 | -12.67 | 0.73 | 0.37 | - | ||
2022/1 | 0.27 | 4.68 | -8.53 | 0.27 | -8.53 | 0.77 | 0.35 | - | ||
2021/12 | 0.26 | 3.07 | -20.29 | 2.7 | -4.47 | 0.74 | 0.36 | - | ||
2021/11 | 0.25 | 2.32 | 12.91 | 2.45 | -2.45 | 0.72 | 0.38 | - | ||
2021/10 | 0.24 | 6.74 | -7.75 | 2.2 | -3.92 | 0.57 | 0.47 | - | ||
2021/9 | 0.23 | 121.27 | -12.84 | 1.96 | -3.43 | 0.44 | 0.57 | - | ||
2021/8 | 0.1 | -8.34 | -61.18 | 1.73 | -2.04 | 0.36 | 0.7 | 重要子公司正原公司因疫情嚴重持續停工,致營收大幅衰退。 | ||
2021/7 | 0.11 | -22.09 | -56.13 | 1.63 | 8.33 | 0.51 | 0.49 | 重要子公司正原公司因疫情嚴重持續停工,致營收大幅衰退。 | ||
2021/6 | 0.14 | -44.25 | -41.32 | 1.52 | 21.48 | 0.68 | 0.34 | - | ||
2021/5 | 0.26 | -8.19 | 47.86 | 1.37 | 36.77 | 0.83 | 0.28 | - | ||
2021/4 | 0.28 | -4.59 | 69.26 | 1.12 | 34.45 | 0.82 | 0.28 | 重要子公司正原公司,2020年因新冠肺炎疫情停工致造成去年營收衰退。 | ||
2021/3 | 0.29 | 17.53 | 41.06 | 0.84 | 25.78 | 0.84 | 0.3 | - | ||
2021/2 | 0.25 | -14.42 | 4.09 | 0.54 | 18.8 | 0.86 | 0.29 | - | ||
2021/1 | 0.29 | -8.77 | 35.15 | 0.29 | 35.15 | 0.83 | 0.3 | - | ||
2020/12 | 0.32 | 46.02 | 25.04 | 2.83 | -14.46 | 0.8 | 0.35 | - | ||
2020/11 | 0.22 | -16.41 | -22.69 | 2.51 | -17.77 | 0.74 | 0.38 | - | ||
2020/10 | 0.26 | 0.85 | -3.83 | 2.29 | -17.27 | 0.79 | 0.36 | - | ||
2020/9 | 0.26 | -1.46 | 4.73 | 2.03 | -18.74 | 0.78 | 0.37 | - | ||
2020/8 | 0.26 | 3.58 | -14.14 | 1.77 | -21.33 | 0.76 | 0.38 | - | ||
2020/7 | 0.25 | 4.21 | -8.88 | 1.5 | -22.48 | 0.67 | 0.43 | - | ||
2020/6 | 0.24 | 40.48 | -4.1 | 1.25 | -24.77 | 0.58 | 0.53 | - | ||
2020/5 | 0.17 | 5.09 | -44.58 | 1.0 | -28.52 | 0.55 | 0.57 | - | ||
2020/4 | 0.17 | -20.49 | -44.33 | 0.83 | -23.89 | 0.61 | 0.5 | - | ||
2020/3 | 0.21 | -13.27 | -27.3 | 0.66 | -16.23 | 0.66 | 0.51 | - | ||
2020/2 | 0.24 | 11.11 | 15.94 | 0.46 | -9.97 | 0.71 | 0.48 | - | ||
2020/1 | 0.22 | -15.59 | -27.89 | 0.22 | -27.89 | 0.0 | N/A | - | ||
2019/12 | 0.26 | -9.72 | -2.87 | 3.31 | 1.0 | 0.0 | N/A | - |